OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002469$7.0456

Shandong Sunway Chemical Group Co Ltd

Commodity ChemicalsVerified

The company maintains a relatively strong liquidity position, with a current ratio of 2.39, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its free cash flow is negative at -24.77 million CNY, and capital expenditures are -16.32 million CNY, suggesting ongoing investment in operations. The debt-to-equity ratio is low at 0.07, and long-term debt is minimal at 188.65 million CNY, indicating a conservative capital structure. Profitability metrics show a return on equity (ROE) of 7.04% and a return on assets (ROA) of 5.04%, which are below the typical thresholds for high-performing chemical firms. The gross profit margin is 16.13% (418.68 million CNY on 2.597 billion CNY revenue), and the operating margin is 7.99% (207.90 million CNY on 2.597 billion CNY revenue). These figures suggest moderate profitability relative to industry peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's primary operations are based in China, and its revenue is entirely derived from domestic sources. Looking ahead, the company is expected to see modest growth in the current fiscal year, with a mean EBIT estimate of 499 million CNY. However, the outlook for the next fiscal year is not explicitly provided. The company's historical revenue growth is not available, but the current valuation multiples suggest a relatively high price-to-earnings ratio of 24.5, indicating investor expectations of future earnings growth. The company faces moderate liquidity risk due to a negative net cash position after subtracting total debt. While dilution risk is currently low, the company has not disclosed any recent share issuance or dilution events. The risk assessment indicates that the company's capital structure is stable, but its free cash flow challenges could impact long-term financial flexibility. Recent filings and transcripts do not provide specific details on strategic initiatives or major operational changes. The company's 10-K and other disclosures are not publicly available in the provided data, limiting insight into recent developments. The company's financial performance and strategic direction appear to be consistent with its historical operations.

30-day price · 002469-1.96 (-21.8%)
Low$6.86High$9.17Close$7.04As of19 May, 00:00 UTC
Profile
CompanyShandong Sunway Chemical Group Co Ltd
Ticker002469.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shandong Sunway Chemical Group Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company maintains a relatively strong liquidity position, with a current ratio of 2.39, indicating that it has sufficient short-term assets to cover its short-term liabilities. However, its free cash flow is negative at -24.77 million CNY, and capital expenditures are -16.32 million CNY, suggesting ongoing investment in operations. The debt-to-equity ratio is low at 0.07, and long-term debt is minimal at 188.65 million CNY, indicating a conservative capital structure. Profitability metrics show a return on equity (ROE) of 7.04% and a return on assets (ROA) of 5.04%, which are below the typical thresholds for high-performing chemical firms. The gross profit margin is 16.13% (418.68 million CNY on 2.597 billion CNY revenue), and the operating margin is 7.99% (207.90 million CNY on 2.597 billion CNY revenue). These figures suggest moderate profitability relative to industry peers. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's primary operations are based in China, and its revenue is entirely derived from domestic sources. Looking ahead, the company is expected to see modest growth in the current fiscal year, with a mean EBIT estimate of 499 million CNY. However, the outlook for the next fiscal year is not explicitly provided. The company's historical revenue growth is not available, but the current valuation multiples suggest a relatively high price-to-earnings ratio of 24.5, indicating investor expectations of future earnings growth. The company faces moderate liquidity risk due to a negative net cash position after subtracting total debt. While dilution risk is currently low, the company has not disclosed any recent share issuance or dilution events. The risk assessment indicates that the company's capital structure is stable, but its free cash flow challenges could impact long-term financial flexibility. Recent filings and transcripts do not provide specific details on strategic initiatives or major operational changes. The company's 10-K and other disclosures are not publicly available in the provided data, limiting insight into recent developments. The company's financial performance and strategic direction appear to be consistent with its historical operations.
Key takeaways
  • The company has a strong current ratio but faces challenges with free cash flow and capital expenditures.
  • Profitability metrics are moderate, with ROE and ROA below industry benchmarks.
  • Revenue is concentrated in a single business segment and geographic region, increasing exposure to regional risks.
  • The company is expected to see modest EBIT growth in the current fiscal year, but long-term growth projections are unclear.
  • Liquidity risk is moderate, and dilution risk is currently low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.60B
Gross profit$418.7M
Operating income$207.9M
Net income$186.5M
R&D
SG&A
D&A
SBC
Operating cash flow$77.4M
CapEx-$16.3M
Free cash flow-$24.8M
Total assets$3.70B
Total liabilities$1.05B
Total equity$2.65B
Cash & equivalents
Long-term debt$188.6M
Valuation
Market price$7.04
Market cap$4.57B
Enterprise value$4.76B
P/E24.5
Reported non-GAAP P/E
EV/Revenue1.8
EV/Op income22.9
EV/OCF61.4
P/B1.7
P/Tangible book1.7
Tangible book$2.65B
Net cash-$188.6M
Current ratio2.4
Debt/Equity0.1
ROA5.0%
ROE7.0%
Cash conversion42.0%
CapEx/Revenue-0.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002469Activity
Op margin8.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin7.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin16.1%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity7.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean EBIT estimate499,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 01:41 UTCJob: 4bd67d7c